-transparent.png){kind=logo}
The enzymes and substrates involved in phosphoinositide signal transduction which have been detected in the nucleus of several cell types have been demonstrated to be responsive to agonists. The complexity of this aspect of inositide function has been previously analyzed in some cell models characterized by a mitogenic or differentiating response to specific factors. An interesting experimental model is represented by human derived osteosarcoma Saos-2 cells, characterized by the expression of high affinity receptors for interleukin 1 alpha (IL-1 alpha), which is one of the most potent stimulators of bone resorption. In particular, we investigated the earliest intracellular events following the binding of IL-1 alpha to its receptor, involving the inositide signal transduction pathway. Saos-2 cells present a partitioning of the phosphoinositidase (PLC) isoforms; in fact, the nucleus contains both PLC beta 1 and gamma 1, while the cytoplasm contains almost exclusively the gamma 1 isoform. IL-1 alpha evokes a rapid and transient increase of the PLC beta 1 activity in the nucleus, which causes the hydrolysis of phosphatidylinositol mono- and bis-phosphate. In response to IL-1 alpha, not only the canonical inositol lipid pathway appears to be involved; also the 3'-phosphorylated lipids generated by phosphatidylinositol 3-kinase (PI 3-K), which may act as second messengers, appear to be affected. In fact, Saos-2 cells present a nuclear PI 3-K activity which can be enhanced by the IL-1 alpha treatment. Among the possible targets of the second messengers released by the nuclear PLC beta 1 activation, we found that some protein kinase C isoforms, namely the epsilon and zeta, which are present within the nucleus, are activated after IL-1 alpha exposure. These activated PKC isoforms, in turn, could modulate the activity of the transcription factor NFkB, which, 5 min after IL-1 alpha treatment, has already translocated to the nucleus and bound to DNA to promote gene activation. The actual role of the inositide pathway in the Saos-2 cell function has also been investigated by utilizing cell clones transfected with the mouse sequence of the PLC beta 1.
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
July 2002,
Cellular and molecular life sciences : CMLS,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
October 1994,
The Journal of membrane biology,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
October 2005,
Histology and histopathology,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
January 1990,
Progress in lipid research,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
January 1996,
Acta physiologica Hungarica,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
January 2001,
International journal of oncology,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
January 1996,
Anticancer research,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
September 2020,
Human & experimental toxicology,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
September 1986,
The Journal of experimental biology,
N M Maraldi, and
S Marmiroli, and
L Cocco, and
S Capitani, and
O Barnabei, and
F A Manzoli
June 2000,
FEBS letters,
